Balyasny Asset Management LLC Pfizer Inc Call Options Transaction History

Balyasny Asset Management LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $370,227 - $425,139	-14,300 Reduced 1.01%	1,401,700 $38.9 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $122 Million - $158 Million	-4,670,000 Reduced 76.73%	1,416,000 $40.8 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $151 Million - $176 Million	4,695,000 Added 337.53%	6,086,000 $202 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $50.2 Million - $58.1 Million	1,391,000 New	1,391,000 $51 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $10.7 Million - $15.9 Million	260,000 Added 1300.0%	280,000 $16.5 Million

Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $2.87 Million - $3.25 Million	-80,000 Reduced 80.0%	20,000 $783,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $157 Million - $200 Million	-4,700,000 Reduced 97.92%	100,000 $3.68 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $79.4 Million - $93.1 Million	2,500,000 Added 108.7%	4,800,000 $176 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $22.6 Million - $27.4 Million	750,000 Added 48.39%	2,300,000 $75.2 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $48.1 Million - $52.9 Million	1,550,000	1,550,000 $55.3 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.